West Pharmaceutical Services, Inc.
WST
$230.11
$6.382.85%
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | 0.25% | 6.38% | |||
Total Other Revenue | -- | -- | |||
Total Revenue | 0.25% | 6.38% | |||
Cost of Revenue | -1.45% | 2.14% | |||
Gross Profit | 3.36% | 15.09% | |||
SG&A Expenses | 1.71% | -1.33% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -100.00% | -- | |||
Total Operating Expenses | -0.55% | 1.33% | |||
Operating Income | 3.06% | 28.73% | |||
Income Before Tax | -0.89% | 26.43% | |||
Income Tax Expenses | 13.58% | 47.95% | |||
Earnings from Continuing Operations | -4.34% | 22.19% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -4.34% | 22.19% | |||
EBIT | 3.06% | 28.73% | |||
EBITDA | 2.71% | 22.86% | |||
EPS Basic | -4.21% | 22.52% | |||
Normalized Basic EPS | 4.56% | 26.52% | |||
EPS Diluted | -3.62% | 22.52% | |||
Normalized Diluted EPS | 4.56% | 26.69% | |||
Average Basic Shares Outstanding | -0.14% | -0.27% | |||
Average Diluted Shares Outstanding | -0.14% | -0.41% | |||
Dividend Per Share | 5.00% | 0.00% | |||
Payout Ratio | 0.10% | -0.19% |